Mercator Medical S.A.
MRC.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | PLN 542,693 | PLN 469,064 | PLN 542,512 | PLN 1,727,349 |
| % Growth | 15.7% | -13.5% | -68.6% | – |
| Cost of Goods Sold | PLN 401,581 | PLN 445,421 | PLN 454,213 | PLN 1,043,547 |
| Gross Profit | PLN 141,112 | PLN 102,828 | PLN 88,299 | PLN 683,802 |
| % Margin | 26% | 21.9% | 16.3% | 39.6% |
| R&D Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| G&A Expenses | PLN 0 | PLN 0 | PLN 61,937 | PLN 61,628 |
| SG&A Expenses | PLN 132,776 | PLN 126,697 | PLN 61,937 | PLN 61,628 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | -PLN 22,768 | PLN 63,246 | PLN 99,766 | PLN 158,741 |
| Operating Expenses | PLN 110,008 | PLN 189,943 | PLN 161,703 | PLN 220,369 |
| Operating Income | PLN 31,104 | -PLN 87,115 | -PLN 181,215 | PLN 463,433 |
| % Margin | 5.7% | -18.6% | -33.4% | 26.8% |
| Other Income/Exp. Net | PLN 10,760 | PLN 83,323 | -PLN 5,000 | PLN 13,792 |
| Pre-Tax Income | PLN 41,864 | -PLN 3,792 | -PLN 186,215 | PLN 477,225 |
| Tax Expense | -PLN 7,968 | PLN 19,044 | PLN 4,571 | PLN 32,373 |
| Net Income | PLN 51,049 | -PLN 19,676 | -PLN 189,622 | PLN 446,865 |
| % Margin | 9.4% | -4.2% | -35% | 25.9% |
| EPS | 5.44 | -2.05 | -19.41 | 44.15 |
| % Growth | 365.4% | 89.4% | -144% | – |
| EPS Diluted | 5.44 | -2.05 | -19.41 | 44.15 |
| Weighted Avg Shares Out | 9,390 | 9,584 | 9,770 | 10,122 |
| Weighted Avg Shares Out Dil | 9,390 | 9,584 | 9,770 | 10,122 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 21,141 | PLN 22,668 | PLN 13,477 | PLN 3,118 |
| Interest Expense | PLN 409 | PLN 832 | PLN 798 | PLN 545 |
| Depreciation & Amortization | PLN 18,790 | PLN 22,119 | PLN 25,671 | PLN 19,306 |
| EBITDA | -PLN 4,709 | -PLN 51,403 | -PLN 159,746 | PLN 497,076 |
| % Margin | -0.9% | -11% | -29.4% | 28.8% |